MediPharm Labs Corp

LABS

Company Profile

  • Business description

    MediPharm Labs Corp is a pharmaceutical company specializing in precision-based cannabinoids. The company operates in one reportable segment, the production and sales of cannabis flower, extracts, and derivative products. Through its wholesale and white-label platforms, MediPharm Labs formulates, develops, processes, packages, and distributes cannabis extracts and cannabinoid-based products to domestic and international markets. Geographically the company has a presence in Canada, Australia, Germany, and other countries and the majority of revenue derives from Canada.

  • Contact

    151 John Street
    BarrieONL4N 2L1
    CAN

    T: +1 705 719-7425

    https://www.medipharmlabs.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    161

Stocks News & Analysis

stocks

A collection of our best stock opportunities

Our latest articles about where we see opportunities in the market.
stocks

Morningstar analyst reacts to Macquarie Group’s earnings

Banking Analyst Nathan Zaia’s analysis of MQG’s results.
stocks

Undervalued ASX share showing progress in global efforts

More clarity on the path forward in the UK.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,931.7031.80-0.35%
CAC 407,800.8833.70-0.43%
DAX 4023,970.36247.14-1.02%
Dow JONES (US)44,837.5664.36-0.14%
FTSE 1009,081.4438.87-0.43%
HKSE25,313.22248.91-0.97%
NASDAQ21,178.5870.270.33%
Nikkei 22540,655.54342.73-0.84%
NZX 50 Index12,893.5317.21-0.13%
S&P 5006,389.771.130.02%
S&P/ASX 2008,670.4027.30-0.31%
SSE Composite Index3,598.400.460.01%

Market Movers